nonprofit logo

New York Genome Center Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 800631734 ✦ New york, NY ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is New York Genome Center Inc?

New York Genome Center Inc, located in New York City, is a leading nonprofit organization specializing in genome sequencing. Over the past seven years, their advanced sequencing laboratory has processed over 86,900 whole genome samples, utilizing five Novaseq systems sequencers. This state-of-the-art technology allows them to carry out large-scale genomics projects efficiently, making significant strides in genetic research and improving human health. Their mission is to operate a world-class genomic research center, using advanced genomics to understand the genetic basis of diseases. With a team of 240 employees, they continue to push the boundaries of scientific discovery.


Official website here: www.nygenome.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 81% (Three-Star out of Four Star Rating)

The New York Genome Center Inc has achieved an overall score of 81% on Charity Navigator, indicating a solid performance in accountability and financial health. With a high percentage of independent board members and a fully compliant audit and oversight committee, the organization demonstrates a commitment to transparency and ethical governance. The absence of material diversion of assets further underscores its financial integrity.

The nonprofit's program expense ratio stands at an impressive 80.61%, reflecting a strong dedication to its mission-driven activities rather than administrative costs. Additionally, the organization adheres to various best practices, including a whistleblower policy and a conflict of interest policy, both of which enhance its operational transparency.

However, while the working capital ratio of 0.49 years might suggest some liquidity concerns, the organization appears to manage its finances effectively overall. The available data suggests that while there are areas for improvement, the New York Genome Center Inc maintains a commendable standard of accountability and impact in the nonprofit sector.


This AI summary has been generated from information found on Charity Navigator.

Is New York Genome Center Inc legitimate?

New York Genome Center Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. New York Genome Center Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $4,231,643
Professional Fundraising Fees: $140
Other Salaries and Wages: $19,467,399

For more financial information, click here


Official website here: www.nygenome.org

What is the mission statement of New York Genome Center Inc?

The New York Genome Center Inc is dedicated to advancing genomic research to discover new biomedical solutions for improving human health. They operate a world-class genomic research center, utilizing advanced genomic techniques to understand the genetic basis of diseases. Their state-of-the-art genome sequencing program has sequenced over 86,900 whole genomes in the past seven years, with the capacity to sequence thousands more each year. Advanced sequencing technology allows them to carry out large-scale genomic projects quickly and efficiently, delving deeper into the genome for greater insights.


Official website here: www.nygenome.org

Who is the CEO of New York Genome Center Inc?

Tom Maniatis is the Principal Officer of New York Genome Center Inc. The CEO's salary of New York Genome Center Inc is $633,696 and their total compensation is $633,696.


Official website here: www.nygenome.org

What is the revenue of New York Genome Center Inc?

New York Genome Center Inc's revenue in 2022 was $67,901,686.


Official website here: www.nygenome.org

Who are the executives of New York Genome Center Inc and what are their salaries?

The average compensation at New York Genome Center Inc during 2022 was $98,746. There are 240 employees and 25 volunteers at New York Genome Center Inc.


Here are 39 key members and their salaries (New York Genome Center Inc's CEO's salary is $633,696 and their total compensation is $633,696):


Russell L Carson Mba (Director & Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ivan G Seidenberg Mba (Director & Co-Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Herb Pardes Md (Director & Exec. Vice Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Gordon F Tomaselli Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bruce Stillman Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Anil Rustgi Md (Director (Thru 03/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Katrina Armstrong Md (Director (As Of 03/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Craig B Thompson Md (Director (Thru 10/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Selwyn Vickers Md (Director (As Of 10/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Dennis S Charney Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dafna Bar-Sagi Phd (Senior Vp, Chief Scientific Officer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kevin J Tracey Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kenneth A Dill Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Richard P Lifton Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Augustine M K Choi Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Eli Casdin (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Nicholas Donofrio (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Joseph E Edelman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
John B Ehrenkranz (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Anthony B Evnin Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
John P Havens (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Weslie R Janeway (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Frank V Sica (Director & Committee Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jim Simons Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Nancy Thornberry (Director (As Of 10/22))
  • Compensation: $0
  • Related: $0
  • Other: $0
Tom Maniatis Phd (Scientific Director & Ceo)
  • Compensation: $633,696
  • Related: $0
  • Other: $0
Elizabeth Brooks O'Brien (Vp & General Counsel)
  • Compensation: $453,705
  • Related: $0
  • Other: $41,087
Maria Joanta (Chief Financial Officer)
  • Compensation: $365,440
  • Related: $0
  • Other: $47,560
Carol Ashe (Chief Business Officer)
  • Compensation: $425,448
  • Related: $0
  • Other: $61,483
Charles Gagnon (Chief Information Officer)
  • Compensation: $329,980
  • Related: $0
  • Other: $47,431
Thomas Lehner (Sci Dir, Neuro Dis Gen)
  • Compensation: $394,617
  • Related: $0
  • Other: $38,366
Soren Germer (Svp, Genome Technologies)
  • Compensation: $424,568
  • Related: $0
  • Other: $35,406
Michael Charles Zody (Scientific Dir, Comp Biology)
  • Compensation: $350,538
  • Related: $0
  • Other: $27,331
Sarah Lesser Avins (Svp, Advancement & Chief Dev. Ofc.)
  • Compensation: $554,010
  • Related: $0
  • Other: $18,417
Shailaja Gargeya (Senior Dir, Software Engineer)
  • Compensation: $320,347
  • Related: $0
  • Other: $18,312
Dayna M Oschwald (Chief Of Staff)
  • Compensation: $268,319
  • Related: $0
  • Other: $35,681
Christopher Phifer Black (Senior Director, Research Computing)
  • Compensation: $244,736
  • Related: $0
  • Other: $42,798
Hannah Goulding (Senior Director, Human Resources)
  • Compensation: $235,875
  • Related: $0
  • Other: $14,269
Jessica Leigh Leitner (Senior Director, Development)
  • Compensation: $227,847
  • Related: $0
  • Other: $21,817


Official website here: www.nygenome.org

Where can I find the form 990 for New York Genome Center Inc?

New York Genome Center Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.nygenome.org

Learn more at the official website: www.nygenome.org

Mission Statement of New York Genome Center Inc

New York Genome Center Inc, a leading genomic research organization, strives to push the boundaries of scientific discovery and improve human health by operating a world-class research facility. Their mission is to advance genomics, utilizing advanced technologies to comprehend the genetic basis of diseases.

The Center's state-of-the-art genomic research center is at the forefront of creating and implementing innovative genomic approaches. With one of the largest whole genome sequencing programs in New York, they have sequenced over 86,900 samples since inception. Their advanced technology includes five Novaseq systems sequencers, enabling them to sequence thousands of genomes annually. This cutting-edge sequencing technology empowers New York Genome Center Inc to execute large-scale genomics projects swiftly and efficiently, and delve deeper into the genome with greater precision.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

New York Genome Center Inc significantly advances genomic research, driving novel biomedical discoveries that enhance human health. With one of the largest whole genome sequencing programs in New York, the Center has sequenced over 86,900 whole genome samples in the past seven years. Equipped with state-of-the-art NovaSeq systems, NYGC possesses the capacity to sequence thousands of genomes each year, enabling large-scale genomic projects with exceptional speed and sample volume.

The organization’s cutting-edge sequencing technology allows for more comprehensive exploration of the genome, increasing efficiency and depth of analysis. This approach not only accelerates understanding of the genetic basis of diseases but also paves the way for new therapeutic strategies. By operating a world-class genomic research facility, NYGC is at the forefront of genomic science, contributing significantly to advancements in health and disease prevention.




This information is meant to be a general summary of New York Genome Center Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$67,901,686 (2022)
Expenses
$72,195,873 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: -$12,410
  • Program Service Revenue: $11,277,968
  • Gross Receipts: $72,179,367

Assets and Liabilities:

  • Total Assets: $181,740,451
  • Total Liabilities: $146,891,982
  • Net Assets: $34,848,469

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

RESEARCH SEQUENCING

Revenue

$9,825,238

CLINICAL SEQUENCING

Revenue

$1,452,730

Organization Details

Founding Year

2010

Principal Officer

Tom Maniatis

Main Address

101 AVENUE OF THE AMERICAS FL 7, NEW YORK, NY, 100131941

NTEE Category

Code: E22 - Health

If you are a representative of New York Genome Center Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.